Phil Law Weblog

The first class action lawsuit over the failed Westpoint venture was filed by the investors, alleges that PIS recommended clients invest in Westpoint’s high-risk mezzanine financing schemes.

Nearly 100 undocumented employees who were fired last week, filed a class action lawsuit against Cafe Express, its parent company Wendy’s International, Inc. and its former law firm.

The lawsuit, which was filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth was dismissed negligence charges and found the drug’s design was not defective.

A securities class action lawsuit has been filed by Law Offices of Howard G. Smith in the United States District Court for the Middle District of Florida on behalf of shareholders who purchased securities of Jabil Circuit Inc. between September 19, 2001 and June 21, 2006, inclusive.

A hearing to consider a proposed $30 million settlement in class-action lawsuits against former executives of McLeod USA has been set by U.S. District Judge Mark Bennett.

A class action lawsuit has been commenced in the United States District Court for the District of Connecticut on behalf of all securities purchasers of ADVO, Inc. from July 6, 2006 through August 30, 2006, inclusive, alleges ADVO and certain of its officers and directors with violations of the Securities Exchange Act of 1934.

The Canadian Internet Policy and Public Interest Clinic has filed a formal objection which has received the support of the Electronic Frontier Foundation to Sony’s Canadian rootkit class action settlement, challenging Sony’s description of the events leading up to the US settlement.

A class Action lawsuit, which was filed by former and current female employees of C.H. Robinson Worldwide for gender discrimination in pay and promotion, has been settled for $15 million.

The nationalwide class action lawsuit, which accused TAP Pharmaceutical Products Inc., Abbott Laboratories and Takeda Pharmaceutical Co. Ltd., three drug makers of overcharging consumers for the prescription drug Lupron, wasb settled for $150 million.

A lawsuit which was filed by the Center for Medicare Advocacy on behalf of two consumer advocacy groups, declared that some of the 230,000 Medicare beneficiaries who last month received erroneous reimbursements of their Medicare drug benefit premiums should not have to repay them.